Sherif M. El-Harazi
Expertise in
1
conditions

Dr. Sherif M. El-Harazi

Ophthalmology
1510 S Central Ave, Ste 300, 
Glendale, CA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
1
conditions
1510 S Central Ave, Ste 300, 
Glendale, CA 

Overview

Sherif El-Harazi is an Ophthalmologist practicing medicine in Glendale, California.

Dr. El-Harazi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Conjunctivitis (Pink Eye), Presbyopia, Diabetic Retinopathy, and Dry Eye Syndrome.

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 4 clinical trials. Dr. El-Harazi is currently accepting new patients.

Specialties

Ophthalmology

Licenses

Ophthalmology in CA

Languages Spoken

English
Armenian
Farsi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Sherif M. El-Harazi, MD Private Practice
1510 S Central Ave, Ste 300, Glendale, CA 91204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye.
A 4 Weeks, Phase II, Multicenter, Randomized, Double-masked, Vehicle-controlled, Parallel Group Study With 12 Weeks of Follow-up to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution vs Vehicle in Moderate to Severe Dry Eye.
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

7 Total Publications

Safety and Efficacy of AGN-241622 for Presbyopia: Results From a First-in-Human, Phase 1/2, Randomized, Vehicle-Controlled Study.
Safety and Efficacy of AGN-241622 for Presbyopia: Results From a First-in-Human, Phase 1/2, Randomized, Vehicle-Controlled Study.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: November 17, 2025
Similar Doctors
Expertise in
11
conditions
Dr. Michael S. Ip
Ophthalmology
Expertise in
11
conditions
Dr. Michael S. Ip
Ophthalmology
Referral may be required

Jules Stein Eye Institute Medical Group

625 S Fair Oaks Ave Ste 280, 
Pasadena, CA 
 (5.3 miles away)
626-817-4747
Languages Spoken:
English
See accepted insurances

Michael Ip is an Ophthalmologist practicing medicine in Pasadena, California. Dr. Ip is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), and Vitrectomy.

Expertise in
26
conditions
Dr. David S. Boyer
Ophthalmology
Expertise in
26
conditions
Dr. David S. Boyer
Ophthalmology
Referral required
Before you request
16661 Ventura Boulevard, Penthouse 900, 
Encino, CA 
 (13.8 miles away)
818-578-7408
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Boyer is an Ophthalmologist practicing medicine in Encino, California. Dr. Boyer is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Boyer is board certified in American Board Of Ophthalmology. Dr. Boyer is currently accepting new patients.

Expertise in
24
conditions
Dr. David Sarraf
Ophthalmology
Expertise in
24
conditions
Dr. David Sarraf
Ophthalmology
Referral may be required

Sherwin J. Isenberg MD Inc

100 Stein Plz, 
Los Angeles, CA 
 (11.4 miles away)
310-825-3090
Languages Spoken:
English
See accepted insurances

David Sarraf is an Ophthalmologist practicing medicine in Los Angeles, California. Dr. Sarraf is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Punctate Inner Choroidopathy, and Vitrectomy.

Frequently Asked Questions about Dr. Sherif M. El-Harazi

How do I make an appointment with Dr. Sherif M. El-Harazi?

You can book an appointment with Dr. Sherif M. El-Harazi by calling their office at 818-265-2255. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sherif M. El-Harazi a top-rated expert for Conjunctivitis (Pink Eye)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sherif M. El-Harazi is classified as an Advanced expert for Conjunctivitis (Pink Eye), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sherif M. El-Harazi specialize in?

While Dr. Sherif M. El-Harazi is a Ophthalmology, they have specific expertise in Conjunctivitis (Pink Eye), Presbyopia, and Diabetic Retinopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Sherif M. El-Harazi participate in research or clinical trials?

Yes. Dr. Sherif M. El-Harazi has published 7 articles and abstracts on conditions like Conjunctivitis (Pink Eye). You can view a list of Dr. Sherif M. El-Harazi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sherif M. El-Harazi accept my insurance?

Dr. Sherif M. El-Harazi accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 818-265-2255 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. El-Harazi's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile